Endogenous ceramide contributes to the transcytosis of oxldl across endothelial cells and promotes its subendothelial retention in vascular wall

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Li, Wenjing ^a,b   Yang, Xiaoyan ^a,b   Xing, Shasha ^a,b   Bian, Fang ^a,b   Yao, Wanjing ^a,b   Bai, Xiangli ^a,b   Zheng, Tao ^a,b   Wu, Guangjie ^a,b   Jin, Si ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDES; DISEASES; PHOSPHOLIPIDS;

ACID SPHINGOMYELINASE; ATHEROSCLEROTIC CHANGES; ATHEROSCLEROTIC LESIONS; DITHIOCARBONATE; ENZYME INHIBITORS; OXIDIZED-LOW DENSITY; SPHINGOMYELIN SYNTHASES; VASCULAR ENDOTHELIAL CELLS;

ENDOTHELIAL CELLS;

CAVEOLIN 1; CAVIN 1; CERAMIDE; DESIPRAMINE; N OLEOYLETHANOLAMINE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN; THERMOZYMOCIDIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; BRIDGED COMPOUND; CERAMIDASE; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; N-OLEOYLETHANOLAMINE; OLEIC ACID; PHOSPHATIDYLCHOLINE-CERAMIDE PHOSPHOCHOLINE TRANSFERASE; PHOSPHOTRANSFERASE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE ACYLTRANSFERASE; THIOKETONE; TRICYCLODECANE-9-YL-XANTHOGENATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL WALL; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; SUBENDOTHELIUM; TRANSCYTOSIS; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BRIDGED COMPOUNDS; CERAMIDASES; CERAMIDES; DESIPRAMINE; ENDOCANNABINOIDS; ENDOTHELIAL CELLS; ETHANOLAMINES; FATTY ACIDS, MONOUNSATURATED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; OLEIC ACIDS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE N-ACYLTRANSFERASE; THIONES; TRANSCYTOSIS; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS); UP-REGULATION;

EID: 84900322463     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/823071     Document Type: Article

References (75)

1. Lindsay A. C., Choudhury R. P., Form to function: current and future roles for atherosclerosis imaging in drug development. Nature Reviews Drug Discovery 2008 7 6 517 529 2-s2.0-44449136941 10.1038/nrd2588 (Pubitemid 351767119)
2. Skålén K., Gustafsson M., Rydberg E. K., Hultén L. M., Wiklund O., Innerarity T. L., Boren J., Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002 417 6890 750 754 2-s2.0-0037071843 10.1038/nature00804 (Pubitemid 34640629)
3. Staels B., Cardiovascular biology: a cholesterol tether. Nature 2002 417 6890 699 701 2-s2.0-0037071851
4. Tabas I., Williams K. J., Borén J., Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007 116 16 1832 1844 2-s2.0-37349021003 10.1161/CIRCULATIONAHA.106.676890 (Pubitemid 350287108)
5. Tabas I., Macrophage death and defective inflammation resolution in atherosclerosis. Nature Reviews Immunology 2010 10 1 36 46 2-s2.0-72949116358 10.1038/nri2675
6. Frank P. G., Pavlides S., Lisanti M. P., Caveolae and transcytosis in endothelial cells: role in atherosclerosis. Cell and Tissue Research 2009 335 1 41 47 2-s2.0-57749189130 10.1007/s00441-008-0659-8
7. Krauss R. M., Burke D. J., Identification of multiple subclasses of plasma low density lipoproteins in normal humans. Journal of Lipid Research 1982 23 1 97 104 2-s2.0-0020060090 (Pubitemid 12112617)
8. Simionescu N., Simionescu M., Palade G. E., Open junctions in the endothelium of the postcapillary venules of the diaphragm. Journal of Cell Biology 1978 79 1 27 44 2-s2.0-0018094276 (Pubitemid 9035436)
9. Tuma P. L., Hubbard A. L., Transcytosis: crossing cellular barriers. Physiological Reviews 2003 83 3 871 932 2-s2.0-0037817352 (Pubitemid 36833216)
10. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., Komatsu R., Matsuo T., Itabe H., Takano T., Tsukamoto Y., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A. E., Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001 103 15 1955 1960 2-s2.0-0035901582 (Pubitemid 32322222)
11. Xu S., Ogura S., Chen J., Little P. J., Moss J., Liu P., LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cellular and Molecular Life Sciences 2013 70 16 2859 2872 10.1007/s00018-012-1194-z
12. Tsimikas S., Witztum J. L., Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 2001 103 15 1930 1932 2-s2.0-0035901607 (Pubitemid 32322217)
13. Verhoye E., Langlois M. R., Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clinical Chemistry and Laboratory Medicine 2009 47 2 128 137 2-s2.0-59849121648 10.1515/CCLM.2009.037
14. Staubach S., Hanisch F.-G., Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Review of Proteomics 2011 8 2 263 277 2-s2.0-79955073961 10.1586/epr.11.2
15. Jin S., Zhou F., Katirai F., Li P.-L., Lipid raft redox signaling: molecular mechanisms in health and disease. Antioxidants & Redox Signaling 2011 15 4 1043 1083 2-s2.0-79960427714 10.1089/ars.2010.3619
16. Jin S., Zhou F., Lipid raft redox signaling platforms in vascular dysfunction: features and mechanisms. Current Atherosclerosis Reports 2009 11 3 220 226 2-s2.0-65449165610 10.1007/s11883-009-0034-6
17. Lajoie P., Nabi I. R., Lipid rafts, caveolae, and their endocytosis. International Review of Cell and Molecular Biology 2010 282 135 163 2-s2.0-77957895194 10.1016/S1937-6448(10)82003-9
18. Lingwood D., Kaiser H.-J., Levental I., Simons K., Lipid rafts as functional heterogeneity in cell membranes. Biochemical Society Transactions 2009 37 5 955 960 2-s2.0-70350172934 10.1042/BST0370955
19. Simons K., Ikonen E., Functional rafts in cell membranes. Nature 1997 387 6633 569 572 2-s2.0-0030949124 10.1038/42408 (Pubitemid 27248754)
20. Symons J. D., Abel E. D., Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide. Reviews in Endocrine and Metabolic Disorders 2013 14 1 59 68 10.1007/s11154-012-9235-3
21. Bismuth J., Lin P., Yao Q., Chen C., Ceramide: a common pathway for atherosclerosis? Atherosclerosis 2008 196 2 497 504 2-s2.0-38349092384 10.1016/j.atherosclerosis.2007.09.018
22. Elojeimy S., Holman D. H., Liu X., el-Zawahry A., Villani M., Cheng J. C., Mahdy A., Zeidan Y., Bielwaska A., Hannun Y. A., Norris J. S., New insights on the use of desipramine as an inhibitor for acid ceramidase. FEBS Letters 2006 580 19 4751 4756 2-s2.0-33746897026 10.1016/j.febslet.2006.07.071 (Pubitemid 44189397)
23. Bhatia R., Matsushita K., Yamakuchi M., Morrell C. N., Cao W., Lowenstein C. J., Ceramide triggers Weibel-Palade body exocytosis. Circulation Research 2004 95 3 319 324 2-s2.0-4043063505 10.1161/01.RES.0000136519.84279.7a (Pubitemid 39056293)
24. Kölzer M., Werth N., Sandhoff K., Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine. FEBS Letters 2004 559 1-3 96 98 2-s2.0-0442323490 10.1016/S0014-5793(04)00033-X (Pubitemid 38186710)
25. Park T.-S., Panek R. L., Rekhter M. D., Mueller S. B., Rosebury W. S., Robertson A., Hanselman J. C., Kindt E., Homan R., Karathanasis S. K., Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice. Atherosclerosis 2006 189 2 264 272 2-s2.0-33750359322 10.1016/j.atherosclerosis.2005.12.029 (Pubitemid 44634484)
26. Keul P., Sattler K., Levkau B., HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Failure Reviews 2007 12 3-4 301 306 2-s2.0-35848933939 10.1007/s10741-007-9038-x (Pubitemid 350176703)
27. Houben E., Hachem J. P., de Paepe K., Rogiers V., Epidermal ceramidase activity regulates epidermal desquamation via stratum corneum acidification. Skin Pharmacology and Physiology 2008 21 2 111 118 2-s2.0-41149127084 10.1159/000114872 (Pubitemid 351440530)
28. Meng A., Luberto C., Meier P., Bai A., Yang X., Hannun Y. A., Zhou D., Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Experimental Cell Research 2004 292 2 385 392 2-s2.0-0346992148 10.1016/j.yexcr.2003.10.001 (Pubitemid 38018853)
29. Li Z., Hailemariam T. K., Zhou H., Li Y., Duckworth D. C., Peake D. A., Zhang Y., Kuo M.-S., Cao G., Jiang X.-C., Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization. Biochimica et Biophysica Acta 2007 1771 9 1186 1194 2-s2.0-34548604943 10.1016/j.bbalip.2007.05.007 (Pubitemid 47404966)
30. Jin S., Yi F., Li P.-L., Contribution of lysosomal vesicles to the formation of lipid raft redox signaling platforms in endothelial cells. Antioxidants & Redox Signaling 2007 9 9 1417 1426 2-s2.0-34547865407 10.1089/ars.2007.1660 (Pubitemid 47255022)
31. Jin S., Yi F., Zhang F., Poklis J. L., Li P.-L., Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 2056 2062 2-s2.0-55449134163 10.1161/ATVBAHA.108.172478
32. Zhang A. Y., Yi F., Jin S., Xia M., Chen Q.-Z., Gulbins E., Li P.-L., Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxidants & Redox Signaling 2007 9 7 817 828 2-s2.0-34250315352 10.1089/ars.2007.1509 (Pubitemid 46919585)
33. Harouse J. M., Collman R. G., Gonzalez-Scarano F., Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line. Journal of Virology 1995 69 12 7383 7390 2-s2.0-0028802209
34. Jan J.-T., Chatterjee S., Griffin D. E., Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. Journal of Virology 2000 74 14 6425 6432 2-s2.0-0033918950 10.1128/JVI.74.14.6425-6432.2000 (Pubitemid 30429809)
35. Teichgräber V., Ulrich M., Endlich N., Riethmüller J., Wilker B., de Oliveira-Munding C. C., van Heeckeren A. M., Barr M. L., von Kürthy G., Schmid K. W., Weller M., Tümmler B., Lang F., Grassme H., Döring G., Gulbins E., Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nature Medicine 2008 14 4 382 391 2-s2.0-41849092177 10.1038/nm1748 (Pubitemid 351499396)
36. Cheung A. L., Isolation and culture of human umbilical vein endothelial cells (HUVEC). Current Protocols in Microbiology 2007 10.1002/9780471729259. mca04bs4 2-s2.0-54749145518
37. Baudin B., Bruneel A., Bosselut N., Vaubourdolle M., A protocol for isolation and culture of human umbilical vein endothelial cells. Nature Protocols 2007 2 3 481 485 2-s2.0-34347217526 10.1038/nprot.2007.54 (Pubitemid 47040010)
38. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R., Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. The Journal of Clinical Investigation 1973 52 11 2745 2756 2-s2.0-0015822275
39. Jia S.-J., Jin S., Zhang F., Yi F., Dewey W. L., Li P.-L., Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. American Journal of Physiology: Heart and Circulatory Physiology 2008 295 4 H1743 H1752 2-s2.0-57049154114 10.1152/ajpheart.00617.2008
40. Vielhaber G., Brade L., Lindner B., Pfeiffer S., Wepf R., Hintze U., Wittern K.-P., Brade H., Mouse anti-ceramide antiserum: a specific tool for the detection of endogenous ceramide. Glycobiology 2001 11 6 451 457 2-s2.0-0034940431 (Pubitemid 32655239)
41. Wang L., Zhen H., Yao W., Bian F., Zhou F., Mao X., Yao P., Jin S., Lipid raft-dependent activation of dual oxidase 1/H2o2/NF- B pathway in bronchial epithelial cells. American Journal of Physiology: Cell Physiology 2011 301 1 C171 C180 2-s2.0-79959816106 10.1152/ajpcell.00363.2010
42. Zinchuk V., Grossenbacher-Zinchuk O., Recent advances in quantitative colocalization analysis: focus on neuroscience. Progress in Histochemistry and Cytochemistry 2009 44 3 125 172 2-s2.0-70349745422 10.1016/j.proghi.2009.03.001
43. Schissel S. L., Jiang X.-C., Tweedie-Hardman J., Jeong T.-S., Camejo E. H., Najib J., Rapp J. H., Williams K. J., Tabas I., Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for athereosclerotic lesion development. The Journal of Biological Chemistry 1998 273 5 2738 2746 2-s2.0-0032579258 10.1074/jbc.273.5.2738 (Pubitemid 28133919)
44. Strelow A., Bernardo K., Adam-Klages S., Linke T., Sandhoff K., Krönke M., Adam D., Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. The Journal of Experimental Medicine 2000 192 5 601 612 2-s2.0-0034605034 10.1084/jem.192.5.601
45. Honeycutt P. J., Niedel J. E., Cytochalasin B enhancement of the diacylglycerol response in formyl peptide-stimulated neutrophils. The Journal of Biological Chemistry 1986 261 34 15900 15905 2-s2.0-0023024146 (Pubitemid 17202833)
46. Seumois G., Fillet M., Gillet L., Faccinetto C., Desmet C., François C., Dewals B., Oury C., Vanderplasschen A., Lekeux P., Bureau F., De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis. Journal of Leukocyte Biology 2007 81 6 1477 1486 2-s2.0-34249674391 10.1189/jlb.0806529 (Pubitemid 46827970)
47. Bian F., Yang X., Zhou F., CRP promotes atherosclerosis by increasing LDL transcytosis across endothelial cells. British Journal of Pharmacology 2014 10.1111/bph.12616
48. Zhang Y., Yang X., Bian F., TNF- α promotes early atheros clerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF- B and PPAR- γ Journal of Molecular and Cellular Cardiology 2014 72 85 94 10.1016/j.yjmcc.2014.02.012
49. Devlin C. M., Leventhal A. R., Kuriakose G., Schuchman E. H., Williams K. J., Tabas I., Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 10 1723 1730 2-s2.0-53449098208 10.1161/ATVBAHA.108.173344
50. Cankova Z., Huang J.-D., Kruth H. S., Johnson M., Passage of low-density lipoproteins through Bruch's membrane and choroid. Experimental Eye Research 2011 93 6 947 955 2-s2.0-84855926087 10.1016/j.exer.2011.10.016
51. Glaros E. N., Kim W. S., Garner B., Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition. Clinical Science 2010 118 12 727 736 2-s2.0-77954076233 10.1042/CS20090452
52. Frias J. C., Williams K. J., Fisher E. A., Fayad Z. A., Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. Journal of the American Chemical Society 2004 126 50 16316 16317 2-s2.0-11444260444 10.1021/ja044911a (Pubitemid 40081918)
53. Matarazzo S., Quitadamo M. C., Mango R., Ciccone S., Novelli G., Biocca S., Cholesterol-lowering drugs inhibit lectin-like oxidized low-density lipoprotein-1 receptor function by membrane raft disruption. Molecular Pharmacology 2012 82 2 246 254 10.1124/mol.112.078915
54. Chun L., Junlin Z., Aimin W., Niansheng L., Benmei C., Minxiang L., Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice 2011 93 1 77 85 2-s2.0-79960560343 10.1016/j.diabres.2011.03. 017
55. Kobayashi K., Nagata E., Sasaki K., Harada-Shiba M., Kojo S., Kikuzaki H., Increase in secretory sphingomyelinase activity and specific ceramides in the aorta of apolipoprotein E knockout mice during aging. Biological and Pharmaceutical Bulletin 2013 36 7 1192 1196 10.1248/bpb.b13-00180
56. Gao D., Pararasa C., Dunston C. R., Bailey C. J., Griffiths H. R., Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. Free Radical Biology and Medicine 2012 53 4 796 806 10.1016/j.freeradbiomed.2012.05. 026
57. Jiang X.-C., Goldberg I. J., Park T.-S., Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. Advances in Experimental Medicine and Biology 2011 721 19 39 2-s2.0-80053604705 10.1007/978-1-4614-0650-1-2
58. Fan Y., Shi F., Liu J., Dong J., Bui H. H., Peake D. A., Kuo M.-S., Cao G., Jiang X.-C., Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 11 2114 2120 2-s2.0-78149282781 10.1161/ATVBAHA.110.213363
59. Jiang X.-C., Paultre F., Pearson T. A., Reed R. G., Francis C. K., Lin M., Berglund L., Tall A. R., Plasma sphingomyelin level as a risk factor for coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 12 2614 2618 2-s2.0-0033673679
60. Grandl M., Bared S. M., Liebisch G., Werner T., Barlage S., Schmitz G., E-LDL and Ox-LDL differentially regulate ceramide and cholesterol raft microdomains in human macrophages. Cytometry A 2006 69 3 189 191 2-s2.0-33645905424 10.1002/cyto.a.20232
61. Schissel S. L., Tweedie-Hardman J., Rapp J. H., Graham G., Williams K. J., Tabas I., Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein: proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. The Journal of Clinical Investigation 1996 98 6 1455 1464 2-s2.0-0029762320 (Pubitemid 26322072)
62. Loidl A., Sevcsik E., Riesenhuber G., Deigner H.-P., Hermetter A., Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. The Journal of Biological Chemistry 2003 278 35 32921 32928 2-s2.0-0042858394 10.1074/jbc.M306088200 (Pubitemid 37055735)
63. McGovern M. M., Pohl-Worgall T., Deckelbaum R. J., Simpson W., Mendelson D., Desnick R. J., Schuchman E. H., Wasserstein M. P., Lipid abnormalities in children with types A and B Niemann Pick disease. The Journal of Pediatrics 2004 145 1 77 81 2-s2.0-3242707891 10.1016/j.jpeds.2004.02.048 (Pubitemid 38962456)
64. Cichon G., Willnow T., Herwig S., Uckert W., Löser P., Schmidt H. H., Benhidjeb T., Schlag P. M., Schnieders F., Niedzielska D., Heeren J., Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage. The Journal of Gene Medicine 2004 6 2 166 175 2-s2.0-4644247930 10.1002/jgm.473 (Pubitemid 40228035)
65. Hibbitt O. C., McNeil E., Lufino M. M. P., Seymour L., Channon K., Wade-Martins R., Long-term physiologically regulated expression of the low-density lipoprotein receptor in vivo using genomic DNA mini-gene constructs. Molecular Therapy 2010 18 2 317 326 2-s2.0-76349091597 10.1038/mt.2009.249
66. Zadelaar S., Kleemann R., Verschuren L., de Vries-Van der Weij J., van der Hoorn J., Princen H. M., Kooistra T., Mouse models for atherosclerosis and pharmaceutical modifiers. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 8 1706 1721 2-s2.0-34547624651 10.1161/ATVBAHA.107.142570 (Pubitemid 47207165)
67. Powell-Braxton L., Véniant M., Latvala R. D., Hirano K.-I., Won W. B., Ross J., Dybdal N., Zlot C. H., Young S. G., Davidson N. O., A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nature Medicine 1998 4 8 934 938 2-s2.0-0031927755 10.1038/nm0898-934 (Pubitemid 28364033)
68. Li X., Xu M., Pitzer A. L., Xia M., Boini K. M., Li P. L., Zhang Y., Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis. Journal of Molecular Medicine 2014 10.1007/s00109-014-1120-y
69. Marathe S., Kuriakose G., Williams K. J., Tabas I., Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 11 2648 2658 2-s2.0-0032725610 (Pubitemid 29536039)
70. Kumano-Kuramochi M., Xie Q., Kajiwara S., Komba S., Minowa T., Machida S., Lectin-like oxidized LDL receptor-1 is palmitoylated and internalizes ligands via caveolae/raft-dependent endocytosis. Biochemical and Biophysical Research Communications 2013 434 3 594 599 10.1016/j.bbrc.2013.03.120
71. Sun S.-W., Zu X.-Y., Tuo Q.-H., Chen L.-X., Lei X.-Y., Li K., Tang C.-K., Liao D.-F., Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacologica Sinica 2010 31 10 1336 1342 2-s2.0-77957745942 10.1038/aps.2010.87
72. Dávalos A., Fernández-Hernando C., Sowa G., Derakhshan B., Lin M. I., Lee J. Y., Zhao H., Luo R., Colangelo C., Sessa W. C., Quantitative proteomics of caveolin-1-regulated proteins: characterization of polymerase I and transcript release factor/cavin-1 in endothelial cells. Molecular & Cellular Proteomics 2010 9 10 2109 2124 2-s2.0-77958009227 10.1074/mcp.M110. 001289
73. Hill M. M., Bastiani M., Luetterforst R., Kirkham M., Kirkham A., Nixon S. J., Walser P., Abankwa D., Oorschot V. M. J., Martin S., Hancock J. F., Parton R. G., PTRF-cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008 132 1 113 124 2-s2.0-37649011760 10.1016/j.cell.2007.11.042
74. Wei Y. M., Li X., Xiong J., Abais J. M., Xia M., Boini K. M., Zhang Y., Li P. L., Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium. The Journal of Pharmacology and Experimental Therapeutics 2013 345 2 170 179 10.1124/jpet.112.201442
75. Liu Y.-X., Han G.-Z., Wu T., Liu P., Zhou Q., Liu K.-X., Sun H.-J., Protective effect of α -lipoic acid on oxidized low density lipoprotein-induced human umbilical vein endothelial cell injury. Pharmacological Reports 2011 63 5 1180 1188 2-s2.0-83155181923